←Back to Expert Scholars
Translational Medicine / 转化医学Ki67 & Proliferation
Miguel Martin
MD, PhD
🏢Hospital Universitario Gregorio Maranon🌐Spain
Professor of Medicine
75
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Miguel Martin leads the Spanish GEICAM breast cancer research group and has directed multiple international adjuvant trials. His work integrates Ki67 and molecular subtype data into treatment decisions. He has contributed to monarchE and KATHERINE trial designs.
Share:
🧪Research Fields 研究领域
Adjuvant trials
GEICAM group
Triple-negative breast cancer
Chemotherapy
Ki67 prognostication
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Miguel Martin 的研究动态
Follow Miguel Martin's research updates
留下邮箱，当我们发布与 Miguel Martin（Hospital Universitario Gregorio Maranon）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment